WCCT Global studies H1N1 in California
The recent study took place in Costa Mesa, California, at the CRO’s Influenza Challenge Research facility. From Jan. 2015 to March 2015, scientists recruited more than 400 study subjects. None of these volunteers had accepted influenza vaccines within the last two years. The goal of the study was to determine the immune response to the H1N1 influenza virus.
"This study demonstrates that up to 30 percent of the general population lacks immunity to H1N1,” Bonnie Bock, M.D., WCCT's infectious disease specialist and principal investigator, said. “This is a population that would be at risk for an H1N1 pandemic, but would also be eligible for inclusion in our influenza challenge research studies. Despite widespread recommendations for all individuals to receive a yearly influenza vaccine, there are those who choose not to receive it and are therefore more susceptible to illness and complications, which raises a concern for public health."
The meeting was held in San Diego, California.
"Our influenza challenge research studies will continue to collect data that ultimately leads to the development of newer vaccines and therapeutics,” Mel Affrime, WCCT Global's senior vice president of translational medicine, said. “We are eager to continue our research in this field and look forward to discovering more about the influenza virus and other infectious diseases."